-transparent.png){kind=logo}
Although the oral anticoagulant acenocoumarol (AC) is very effectively metabolized by the intestinal microflora to its amino metabolite, under clinical conditions this route of AC-disposition is of no importance because the compound is rapidly absorbed from its pharmaceutical application form. Only when the gastro-intestinal absorption is retarded, for instance by using a capsule as vehiculum, are appreciable amounts of reduced metabolites recovered in urine.
Related Publications
H H Thijssen, and
L G Baars, and
M J Hazen, and
A E Van den Bogaard
January 1992,
Zhurnal mikrobiologii, epidemiologii i immunobiologii,
H H Thijssen, and
L G Baars, and
M J Hazen, and
A E Van den Bogaard
September 1989,
Nutrition reviews,
H H Thijssen, and
L G Baars, and
M J Hazen, and
A E Van den Bogaard
May 1973,
Journal of bacteriology,
H H Thijssen, and
L G Baars, and
M J Hazen, and
A E Van den Bogaard
February 1965,
Ceskoslovenska hygiena,
H H Thijssen, and
L G Baars, and
M J Hazen, and
A E Van den Bogaard
November 1984,
Xenobiotica; the fate of foreign compounds in biological systems,
H H Thijssen, and
L G Baars, and
M J Hazen, and
A E Van den Bogaard
October 1988,
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
H H Thijssen, and
L G Baars, and
M J Hazen, and
A E Van den Bogaard
March 1997,
The Journal of pharmacy and pharmacology,
H H Thijssen, and
L G Baars, and
M J Hazen, and
A E Van den Bogaard
January 1982,
Drug metabolism and disposition: the biological fate of chemicals,
H H Thijssen, and
L G Baars, and
M J Hazen, and
A E Van den Bogaard
January 1977,
Uspekhi sovremennoi biologii,
H H Thijssen, and
L G Baars, and
M J Hazen, and
A E Van den Bogaard
January 1968,
Acta pharmacologica et toxicologica,
